Centene (CNC) Competitors $25.23 +0.02 (+0.09%) Closing price 08/7/2025 03:59 PM EasternExtended Trading$25.22 -0.02 (-0.07%) As of 08/7/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CNC vs. ELV, MOH, SEM, HUM, UNH, CI, JYNT, AEMD, BDX, and EWShould you be buying Centene stock or one of its competitors? The main competitors of Centene include Elevance Health (ELV), Molina Healthcare (MOH), Select Medical (SEM), Humana (HUM), UnitedHealth Group (UNH), Cigna Group (CI), Joint (JYNT), Aethlon Medical (AEMD), Becton, Dickinson and Company (BDX), and Edwards Lifesciences (EW). These companies are all part of the "medical" sector. Centene vs. Its Competitors Elevance Health Molina Healthcare Select Medical Humana UnitedHealth Group Cigna Group Joint Aethlon Medical Becton, Dickinson and Company Edwards Lifesciences Centene (NYSE:CNC) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, media sentiment, analyst recommendations, dividends, earnings and profitability. Which has stronger earnings & valuation, CNC or ELV? Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCentene$163.07B0.08$3.31B$4.046.25Elevance Health$177.01B0.36$5.98B$23.5012.07 Is CNC or ELV more profitable? Elevance Health has a net margin of 2.83% compared to Centene's net margin of 1.15%. Elevance Health's return on equity of 17.59% beat Centene's return on equity.Company Net Margins Return on Equity Return on Assets Centene1.15% 9.57% 3.10% Elevance Health 2.83%17.59%6.36% Do analysts rate CNC or ELV? Centene currently has a consensus target price of $42.20, indicating a potential upside of 67.24%. Elevance Health has a consensus target price of $418.19, indicating a potential upside of 47.43%. Given Centene's higher probable upside, equities research analysts plainly believe Centene is more favorable than Elevance Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Centene 1 Sell rating(s) 13 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.12Elevance Health 0 Sell rating(s) 6 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.67 Do insiders & institutionals believe in CNC or ELV? 93.6% of Centene shares are held by institutional investors. Comparatively, 89.2% of Elevance Health shares are held by institutional investors. 0.4% of Centene shares are held by company insiders. Comparatively, 0.3% of Elevance Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more risk and volatility, CNC or ELV? Centene has a beta of 0.4, indicating that its share price is 60% less volatile than the S&P 500. Comparatively, Elevance Health has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Does the media favor CNC or ELV? In the previous week, Centene had 43 more articles in the media than Elevance Health. MarketBeat recorded 69 mentions for Centene and 26 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.35 beat Centene's score of 0.37 indicating that Elevance Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Centene 19 Very Positive mention(s) 8 Positive mention(s) 36 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Neutral Elevance Health 23 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive SummaryElevance Health beats Centene on 12 of the 16 factors compared between the two stocks. Get Centene News Delivered to You Automatically Sign up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CNC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNC vs. The Competition Export to ExcelMetricCenteneMED IndustryMedical SectorNYSE ExchangeMarket Cap$12.38B$34.82B$5.48B$20.70BDividend YieldN/A67.98%4.00%3.67%P/E Ratio6.258.7729.8828.64Price / Sales0.081.36440.4557.35Price / Cash2.557.9535.9423.59Price / Book0.452.278.104.32Net Income$3.31B$2.64B$3.26B$995.66M7 Day Performance-2.65%1.76%0.65%1.91%1 Month Performance-22.55%-11.00%2.44%-0.54%1 Year Performance-66.58%-38.42%27.59%14.76% Centene Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNCCentene4.9528 of 5 stars$25.23+0.1%$42.20+67.2%-66.3%$12.38B$163.07B6.2560,500Trending NewsELVElevance Health4.9329 of 5 stars$274.84+0.1%$418.19+52.2%-45.6%$61.89B$177.01B11.70104,200Positive NewsMOHMolina Healthcare4.9808 of 5 stars$157.84+1.7%$244.55+54.9%-53.2%$8.55B$40.65B7.7818,000Trending NewsInsider TradeSEMSelect Medical4.9971 of 5 stars$11.97-4.8%$24.60+105.5%-62.9%$1.54B$5.19B11.2944,100Dividend AnnouncementHigh Trading VolumeHUMHumana4.6949 of 5 stars$247.07-0.1%$281.62+14.0%-25.9%$29.72B$117.76B18.9665,680UNHUnitedHealth Group4.9956 of 5 stars$240.94+1.3%$371.67+54.3%-56.8%$218.57B$400.28B10.44400,000Trending NewsAnalyst ForecastCICigna Group5 of 5 stars$267.26+1.9%$376.56+40.9%-17.9%$71.34B$247.12B14.5973,500Analyst ForecastJYNTJoint3.722 of 5 stars$11.18+2.3%$15.50+38.6%-10.2%$171.05M$51.90M-19.28320Earnings ReportAEMDAethlon Medical1.3947 of 5 stars$1.21+4.3%$56.00+4,528.1%-42.8%$3.13M$570K-0.1010Upcoming EarningsBDXBecton, Dickinson and Company4.4394 of 5 stars$178.99+1.5%$212.88+18.9%-19.4%$51.30B$20.18B34.1674,000Trending NewsEarnings ReportGap UpEWEdwards Lifesciences4.7774 of 5 stars$80.08+0.9%$85.71+7.0%+27.4%$46.97B$5.44B11.5215,800Trending NewsAnalyst Forecast Related Companies and Tools Related Companies ELV Alternatives MOH Alternatives SEM Alternatives HUM Alternatives UNH Alternatives CI Alternatives JYNT Alternatives AEMD Alternatives BDX Alternatives EW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CNC) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centene Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Centene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.